My energy levels are through the roof, and the brain fog that used to drag me down is completely gone
We are conveniently located in Shirley, Southampton, making it easy for you to access expert care
In contrast, those on higher doses for obesity treatment might experience more pronounced gastrointestinal side effects, including heartburn and acid regurgitation
Heres what they found: In the diabetes group: 17 out of 194 patients taking semaglutide developed NAION ( 8.9% ) 6 out of 516 patients taking non-semaglutide drugs developed NAION ( 1.8% ) In the overweight or obese group: 20 out of 361 patients taking semaglutide developed NAION ( 6.7% ) 3 out of 618 patients taking non-semaglutide drugs developed NAION ( 0.8% ) We can see from these numbers that more people who were taking semaglutide developed this eye condition, compared with those who were taking different medications
I mean, do we have new classes or evolution of the drug manufacturing, if you will, that addresses the side effects or any other, any other actions of the drugs